Kanion Pharmaceutical

AASTOCKS · Jan 20 at 08:32 PM

"Large Firms" China Merchants Securities initiates coverage on Kanion Pharmaceutical, expects the impact of centralized procurement to be digested

Zhitong · Oct 29, 2025 at 04:55 AM

Kanion Pharmaceutical: Wholly-owned subsidiary's drug receives approval for additional indications

Wallstreetcn · Aug 28, 2025 at 12:16 AM

A-share weight loss drug concept stocks continued to weaken in the afternoon, Menovo hit the limit down, Medicilon and Kanion Pharmaceutical fell over 7%, SDKX and HISOAR had the largest declines

Wallstreetcn · Aug 19, 2025 at 03:25 AM

The three major A-share indices rose collectively, with a significant increase in the biopharmaceutical sector. CPO continues to squeeze shorts, while Hong Kong stocks fluctuated and fell, tech stocks retreated, and government bonds and commodities declined

Zhitong · Aug 18, 2025 at 04:19 AM

Kanion Pharmaceutical: Clinical trial for Jianpi Shugan Guben Granules approved

Zhitong · Aug 11, 2025 at 08:36 PM

The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also rising